1 / 22

PTEN ( P hosphatase and Ten sin Homolog) a.k.a. MMAC1 , TEP1

PTEN ( P hosphatase and Ten sin Homolog) a.k.a. MMAC1 , TEP1. Raymond Stadiem. PTEN - Overview. What is PTEN?  Biochemistry/Cell Biology of PTEN protein Biological function of the Pten gene Why did Peifer and Duronio want us to know about PTEN?.

sean-fuller
Download Presentation

PTEN ( P hosphatase and Ten sin Homolog) a.k.a. MMAC1 , TEP1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. PTEN (Phosphatase and Tensin Homolog)a.k.a. MMAC1 , TEP1 Raymond Stadiem

  2. PTEN - Overview • What is PTEN? Biochemistry/Cell Biology of PTEN protein • Biological function of the Pten gene • Why did Peifer and Duronio want us to know about PTEN?

  3. Many proto-oncogenes are kinases (ex: Ras, Src) THEREFORE, it would make sense if there existed tumor suppressors, which regulate this activity by being … PHOSPHATASES

  4. What is PTEN? • PTEN was discovered in 1997 as the first tumor suppressor phosphatase • Phosphatase and Tensin Homolog

  5. PTEN is a phosphatase with two types of substrates (1)Lipid substrate (primary substrate)-involved in cell signaling key target: phosphatidylinositol 3,4,5-trisphosphate(P3) Yamada et al., 2001

  6. PTEN and PI-3 Kinase act as antagonists in lipid signaling Comer et al., 2002

  7. PTEN activation of Akt/PKB • Initiated by binding of growth factors (ex:TGF, Insulin) to receptors • Upon ligand binding to growth factor receptor, PI-3 Kinase is activated • PI-3 Kinase phosphorylates and activates PtdIns(3,4,5)P3 • PtdIns(3,4,5)P3 signals Akt/PKB • PTEN dephosphorylates and inhibits PtdIns(3,4,5)P3(level of regulation)

  8. PTEN is a lipid 3-phosphatase, which signals down the PI3 kinase/AKT proapoptotic pathway. Backman et al.

  9. Outcomes of the Akt/PKB pathway • Role in proliferation complicated • PTEN does not merely block proliferation because studies showed that normal bacteria cells expressing PTEN can still undergo rapid proliferation (Liliental et al., 2000) • Role in apoptosis more clear • Re-expression of PTEN in several carcinoma cell lines induces apoptosis (Li et al, 1998) • Especially important is Anoikis, a form of apoptosis that occurs when cells lose contact with the e.c.m. -mediates the cell’s “anchorage dependence” (Davies et al., 1998)

  10. PTEN is a phosphatase with two types of substrates (part 2) • (2) PTEN may be also a weak protein phosphatase for protein phosphate substrates - can remove phosphate groups from Ser, Thr, and Tyr residues (mechanisms still unclear) • 2 cytoplasmic phosphoprotein substrates: Focal Adhesion Kinase (FAK) and adapter protein Shc • Pathway activated by Integrins and other transmembrane receptors and leads to control of mobility and adhesion of cells

  11. Reported Sites of Action of PTEN Yamada et al. 2001

  12. Localization of signaling proteins during migration • PI3K and PTEN show reciprocal localizations during chemotaxis Comer et al., 2002

  13. PTEN has an N-Terminal Phosphatase Domain and C-Terminal C2 Domain Lee et al., 1999

  14. What about the Pten gene?

  15. Pten is a tumor suppressor gene that is essential for embryonic development • Pten gene located on Chrom 10 (10q23) • Several different Pten null mice lines were generated-produced varying results depending upon which genetic background of mouse was used (e.g.129SvEv vs. C57Bl6) • But in all cases mice do NOT survive to birth  PTEN required for embryogenesis

  16. Pten -/- cells show increased ability to develop teratomas Di Cristofano et al., 1998

  17. Pten is a key player in 3 human autosomal dominant diseases • Cowden Disease (CD),Lhermitte-Duclos Disease (LDD),Bannayan-Zonana Syndrom (BZS) • In all 3 disorders, germline mutations in PTEN have been observed • Still unclear why mutation in one gene leads to 3 related yet distinct disorders • Develop hamartomas of the skin, thyroid, breast, GI tract, CNS, and endometrium • Breast cancers develop in 25-50% of affected women and thyroid cancer in 3-10% of all affected individuals Ali et al., 1999

  18. Harmatomas, a common symptom • 3 PTEN related diseases characterized by multiple harmatomas • A focal malformation that grows by cellular proliferation more rapidly than normal and continues to grow after the stimuli that initiated the new growth cease • results from faulty development in an organ; • composed of an abnormal mixture of tissue elements, or an abnormal proportion of a single element, normally present in that site, which develop and grow at virtually the same rate as normal components, and are not likely to result in compression of adjacent tissue (in contrast to a neoplasm). www.uveitis.org/Enhanced/ MD_info/md_Cowden_sy.htm

  19. PTEN: What might go wrong? With PTEN Without PTEN Echelon Biosciences

  20. How is Pten involved in cancer? • Most frequently mutated gene identified yet in endometrial cancers (33-55% of tumors examined)-Mostly FS, MS, and NS mutations • Of 647 Malignant Glial Tumors examined, 24% showed mutations in PTEN- mostly MS and FS mutations • Ovarian tumors (of endometriod origin) showed mutations in 26% of tumors - mostly MS, FS, and NS mutations • Prostate Carcinoma-mutations in 18% of tumors-Homozygous Deletions, and FS mut. Ali et al., 1999

  21. Summary • PTEN is both a lipid and protein phosphatase • Shown to be involved in pathways that involve apoptosis (or anoikis), mobility, and cell adhesion • PTEN is necessary for embryogenesis and may also control tumor development in mice • PTEN involved in 3 major genetic diseases with mutations in one gene that cause similar yet distinct phenotypes • PTEN mutated in many cancers but more needs to be learned about the pathways involved to better understand how cancers arise and to determine how to design new therapeutic treatments

  22. “PTEN appears to serve as a hub or switchport linking complex signaling pathways. Its disruption…can be likened to disrupting a hub on the internet…(what we have learned about) possible regulations still need clarification.” Yamada et al. 2001

More Related